Transforming biological waste into high-value science.
A multidisciplinary R&D facility for advanced biomaterials.
- Advanced biochemical extraction technologies
- Peptide research & formulation development
- Waste-to-value bioresource processing
- Innovation aligned with DSIR & global standards

Innovating today for a healthier tomorrow
A complete view of our CRO services, patented technologies, dosage formats and therapeutic focus areas — all in one frame.
Core scientific services
From extraction to lyophilization — an integrated pipeline transforming bio-resources into high-value molecules.
Protein Extraction
Advanced biochemical extraction from goat, poultry, fish and plant bio-resources.
Peptide Innovation
Isolation, fractionation and characterization of natural therapeutic peptides.
Enzyme Engineering
Industrial-scale enzymatic hydrolysis and bioreactor process development.
Chromatography
Ion-exchange and size-exclusion separation for high-purity outputs.
Lyophilization
Freeze-drying for thermostable, shelf-stable pharmaceutical formulations.
Nano Delivery
Next-generation nano-peptide drug delivery systems and oral depots.
Built for impact, designed for scale
Indigenous IP
India-first peptide platform addressing global supply gaps for Lunasin, Ovokinin & Cyclotides.
Waste-to-Value
Sustainable conversion of poultry, marine and animal waste into pharmaceutical-grade molecules.
Pharma-ready
GMP-aligned processes with future-ready scale-up for biosimilars and novel formulations.
Global Standards
Quality systems aligned to DSIR, US-FDA and EU-EMA regulatory expectations.
Our process & forward path
How we work
Step 01 — Source
Sustainable bio-resource intake & qualification
Step 02 — Extract
Hydrolysis, ultrafiltration and primary fractionation
Step 03 — Purify
Chromatography to research / pharma grade purity
Step 04 — Formulate
Lyophilization & advanced delivery formulation
Where we are heading
Natural peptide extraction facility commissioning
GLP-1 peptide research program launch
Nano-delivery platform pilot batches
International regulatory filings (US / EU)
Illustrative R&D programs
Representative R&D programs spanning keratin bioconversion, marine collagen, plant peptides and lyophilized delivery.
Keratin Bioconversion
Enzymatic hydrolysis pipeline converting waste poultry feathers into low-molecular-weight bioactive keratin peptides for cosmeceutical formulators.
Marine Collagen
Acid-enzymatic extraction from fish processing waste delivering high-purity type-I collagen for nutraceutical and wound-care use.
Plant Peptide Discovery
Discovery program identifying naturally occurring cyclotides and lunasin from indigenous Indian botanicals for oncology and metabolic indications.
Lyophilized Delivery
Freeze-dried foam matrices stabilizing thermo-sensitive peptides for ambient-temperature distribution across emerging markets.
High-value peptide segment
Core product lines spanning extracts, enzymes, bio-fertilizers and lyophilized formulations — anchored by a high-value natural peptide pipeline.
| Peptide | Source | Application |
|---|---|---|
| Lunasin | Plant | Anti-cancer |
| Ovokinin | Egg | Hypertension |
| Lactoferricin | Milk | Antimicrobial |
| Cyclotides | Herbs | Drug delivery |
| Collagen peptides | Animal | Cosmeceutical |
What partners say
“Their keratin bioconversion pipeline gave us a clean, traceable supply for our cosmeceutical line — and the science is genuinely world-class.”
Dr. R. SharmaR&D Director, Cosmoderm Labs
“Working with Nanimalogy on marine collagen took our nutraceutical formulation from concept to clinical-grade in under a year.”
Anita VermaCEO, BlueOcean Nutra
“A rare combination of deep biochemistry expertise and pragmatic, scale-aware engineering. Exactly what India needs in peptides.”
Prof. K. IyerIIT Delhi, Bioengineering